💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
|
🏷️ 产品编码
RB9T37014685
|
🧬 中文名称
Lintuzumab ELISA试剂盒(靶标:)
|
|
📝 英文名称
Lintuzumab ELISA Kit
| |
|
🔬 应用
ELISA
| |
|
🔢 登录号
P20138
|
🔹 检测方法
Colorimetric
|
|
🔹 灵敏度
0.156 μg/ml
|
🔹 检测范围
0.31-5 μg/mL
|
|
🔹 回收率
80-120%
|
🔹 样本类型
Plasma, Serum
|
|
🔹 检测类型
Quantitative
|
🔹 背景信息
Lintuzumab is a humanized monoclonal antibody, HuM195, that targets the cell surface antigen CD33 that is expressed on the vast majority of acute myeloid leukemia (AML) cells. [225Ac]Ac-lintuzumab clinical trials were discussed in detail in reference. An initial phase I dose-escalation trial demonstrated that for a single infusion of [225Ac]Ac-lintuzumab in patients with relapsed or refractory acute myeloid leukemia, the maximum tolerated dose (MTD) was determined to be 111 kBq/kg with antileukemic activity across all dose levels. No evidence of radiation-induced nephrotoxicity was seen. Peripheral blasts were eliminated in 63% of the patients at doses of >37 kBq/kg. Bone marrow blast reduction was observed in 67% of patients. Subsequently, a multicenter phase I dose-escalation trial was conducted to define MTD, toxicity, and response rate of fractionated-dose [225Ac]Ac-lintuzumab when combined with low-dose cytarabine (LDAC) in older patients with untreated AML who were not candidates for intensive chemotherapy.
|
|
🏷️ 别名
225Ac-lintuzumab, HuM195, SGN-33, SMART M195, HuM195, 166089-32-3
| |
❄️ 稳定性和储存
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
🚚 运输条件
2-8 ℃
⚠️ For Research Use Only.